QUOTED. May 22, 2018. Tamara Syrek Jensen.
Executive Summary
US FDA and the Centers for Medicare and Medicaid Services is working on a joint medical device parallel review pilot program – and now CMS is working with the National Institutes of Health (NIH), too. See what CMS' Tamara Syrek Jensen said about it here.
"We're trying to develop evidence to support coverage determinations by coordinating efforts between FDA, NIH and CMS. So while you're not seeing a lot of NCDs out there, what I think is really happening is a lot of work behind the scenes to develop evidence needed for a National Coverage Determination." – Tamara Syrek Jensen, director of the evidence and analysis group, Centers for Medicare and Medicaid Services (CMS)
Click here for a free trial of Medtech Insight